製品詳細
Application
- Immunization
- Cell based assay (FACS or functional assay)
- Screening (ELISA)
Synonyms
CC chemokine receptor 8, CDw198, ChemR1, CKRL1, CKR-L1, CKRL1, CY6, GPRCL1, GPRCY6, GPR-CY6, TER-1
Source
Human CCR8 Protein (VLP) (CC8-H52P5) is expressed from human 293 cells (HEK293). It contains AA Asp 2 - Ser 318 (Accession # P51685-1).
Predicted N-terminus: Asp
Molecular Characterization
Within the expressed region, several mutations were introduced to optimize the protein expression and stability.
*The isotype control of empty/mock VLP (Cat. No. VLP-N5213) is sold separately and not included in protein, you can follow the link for product information.
Structure

Virus-like particles (VLPs) are protein particles that mimic the shape of viruses but lack a viral genome, and incorporating transmembrane proteins on the external surface.
Synthesis Process
Envelope virus-like particles (eVLPs) are produced by co-expressing target membrane proteins with viral structural proteins in mammalian cells, enabling native embedding of membrane proteins into the lipid bilayer during VLP budding. This approach preserves authentic conformation, post-translational modifications, and orientation, while creating a completely detergent-free environment with repetitive multivalent display and strong immunogenicity making them ideal for immunization, binding assays in antibody discovery and screening (ELISA), and cell-based assays such as FACS, etc.
Endotoxin
Less than 1.0 EU per μg by the LAL method / rFC method.
Purity
>95% as determined by SEC-HPLC.
Formulation
The VLPs are highly immunogenic, so the immunization strategy should be optimized (antigen dose, regimen and adjuvant).
Supplied as 0.2 μm filtered solution in PBS, Arginine, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Shipping
This product is supplied and shipped with dry ice, please inquire the shipping cost.
Storage
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- The product MUST be stored at -70°C or lower upon receipt;
- -70°C for 12 months under sterile conditions.
ACRO Quality Management System
お客様はこちらも閲覧
データ表示
SEC-HPLC

The purity of Human CCR8 Protein (VLP) (Cat. No. CC8-H52P5) was greater than 95% as determined by SEC-HPLC.
Bioactivity-ELISA

Immobilized Human CCR8 Protein (VLP) (Cat. No. CC8-H52P5) at 2 μg/mL (100 μL/well) can bind Anti-CCR8 Antibody, Human IgG1 with a linear range of 0.05-3 ng/mL (QC tested).
Protocol
ELISA comparison of human CCR8 (virus-like particles) using anti-CCR8 antibody shows ACRO (Cat. No. CC8-H52P5) has superior bioactivity to Company S (Routinely tested).
Protocol
Identity-DLS

The mean peak Radius of VLP is 60-85 nm with more than 95% intensity as determined by dynamic light scattering (DLS).
ユーザーレビュー コメントを投稿

バックグランド
最新の進展
- 英語名:
C-C chemokine receptor type 8
- カテゴリ:
- 市販の医薬品数:
0 詳細
- 治験医薬品数:
20 詳細
- 最新の開発ステージ:
Phase 3 Clinical
メールアドレス
order.jp@acrobiosystems.comお問い合わせ
グローバル:+1 800-810-0816(Toll Free)



















